×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Gufic Biosciences Limited | 2,322.00 | 124.24 | 2,314.10 | 1.24 | 3,590 | 58.0 |
| Advanced Enzyme Technologies Limited | 1804.18 | 431.83 | 1719.49 | 3.79 | 3580 | 26.2 |
| Unichem Laboratories Limited | 5329.7 | 2642.9 | 5211.7 | 37.47 | 3372 | 27.0 |
Gufic BioSciences Ltd., with Security Code 509079, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 214.9 | 201.8 | 195.0 | 202.8 | 204.2 | 207.8 | 205.0 | 226.9 |
| Expenses | 175.5 | 165.3 | 160.8 | 167.0 | 165.6 | 173.9 | 178.4 | 194.6 |
| Operating Profit | 39.4 | 36.5 | 34.2 | 35.8 | 38.6 | 33.9 | 26.7 | 32.3 |
| OPM % | 18.32% | 18.07% | 17.55% | 17.64% | 18.92% | 16.33% | 13.01% | 14.25% |
| Other Income | 0.3 | 0.4 | 0.9 | 1.3 | 0.1 | 1.9 | 0.4 | 0.9 |
| Interest | 4.5 | 3.2 | 3.6 | 4.6 | 5.2 | 4.9 | 8.4 | 9.2 |
| Depreciation | 4.3 | 4.1 | 4.3 | 4.3 | 4.3 | 4.6 | 7.8 | 7.7 |
| Profit before tax | 30.9 | 29.6 | 27.1 | 28.1 | 29.3 | 26.3 | 10.8 | 16.3 |
| Tax % | -25% | -24.7% | -26.1% | -25.8% | -25.6% | 26.5% | -26% | 25.8% |
| Net Profit | 23.2 | 22.3 | 20.0 | 20.9 | 21.8 | 19.3 | 8.0 | 12.1 |
| EPS in Rs | 2.39 | 2.23 | 2 | 2.08 | 2.17 | 1.93 | 0 | 1.2 |
| Metrics | Mar 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Dec 2025 | Dec 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 205.0 | 237.1 | 231.4 | 231.4 | 231.4 | 231.4 | 231.4 | 231.4 |
| Expenses | 178.6 | 199.2 | 198.4 | 198.4 | 198.4 | 198.4 | 198.4 | 198.4 |
| Operating Profit | 26.5 | 37.8 | 33.0 | 33.0 | 33.0 | 33.0 | 33.0 | 33.0 |
| OPM % | 12.91% | 15.97% | 14.25% | 14.25% | 14.25% | 14.25% | 14.25% | 14.25% |
| Other Income | 0.4 | 2.1 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
| Interest | 8.4 | 9.6 | 8.4 | 8.4 | 8.4 | 8.4 | 8.4 | 8.4 |
| Depreciation | 7.8 | 7.8 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 |
| Profit before tax | 10.6 | 22.6 | 17.7 | 17.7 | 17.7 | 17.7 | 17.7 | 17.7 |
| Tax % | -26.6% | 25.6% | -29.9% | 29.9% | 29.9% | 29.9% | 29.9% | 29.9% |
| Net Profit | 7.7 | 16.8 | 12.4 | 12.4 | 12.4 | 12.4 | 12.4 | 12.4 |
| EPS in Rs | 0 | 1.68 | 0 | 1.24 | 1.24 | 1.24 | 1.24 | 1.24 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 32% |
| 3 Years: | 26% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 47% |
| 3 Years: | 19% |
| 1 Year: | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 47% |
| 3 Years: | 19% |
| 1 Year: | 10% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|